KLOW Blend
GHK + KPV + LL-37 + ?.
- Sizes available
- 80mg
- Lab certificate (COA)
- Supplier-published sample
· Research-grade only · Not for human consumption · 21+ ·
Multi-peptide healing blend (GHK-Cu, KPV, LL-37, and others). Skin and recovery.
Mechanism · Combined healing peptide stack (copper-binding + anti-inflammatory + antimicrobial).
Best for. Not for.
Best for
- Users pursuing multi-mechanism skin and wound recovery
- Users with prior GHK-Cu, KPV, and LL-37 monotherapy experience (ready for the blend stage)
- Topical and subcutaneous injection both supported
Not for
- First-time users of each component should confirm individual tolerance first
- Active infection or immunocompromised state (LL-37 immunomodulation)
- Active malignancy or cancer history
- Pregnancy or nursing
Mechanism, dose, ramp, risk.
- Mechanism
- Multi-peptide healing blend, popular in protocol spaces.Source · PEPVERA editorial
- Target dose
- Per protocol.Source · PEPVERA editorial
- Ramp
- 8 weeks.Source · PEPVERA editorial
- Risks
- Per components.Source · PEPVERA editorial
Compared to its siblings.
KLOW Blend
Multi-peptide healing blend (GHK-Cu, KPV, LL-37, and others). Skin and recovery.
Pros
- · Multi-mechanism skin and antimicrobial coverage versus BPC-TB-500 healing focus.
- · Broader mechanism than single-target GHK-Cu monotherapy.
Cons
- · Smaller evidence base than BPC-157 plus TB-500 combination.
- · No FDA cosmetic ingredient status; GHK-Cu carries that.
- · Cannot match GHK-Cu's direct topical application use case.
BPC-157 + TB-500 Blend
BPC-157 + TB-500. Validated healing blend.
Pros
- · BPC and TB synergy consensus.
- · Larger evidence base.
Cons
- · Skin / antimicrobial effect weaker
See BPC-157 + TB-500 Blend →
GHK-Cu
Copper-binding monotherapy. FDA cosmetic ingredient with deep evidence.
Pros
- · FDA cosmetic ingredient
- · Direct topical application
Cons
- · Single-mechanism only
See GHK-Cu →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 3 suppliers
| Supplier | Price | COA | Ships | |
|---|---|---|---|---|
| Royal PeptidesUS | $90$1.13/mg · 80mg | Sample COA published | 3 days | Out of stock |
| Ameano PeptidesUS | $98$1.23/mg · 80mg | Sample COA published | 2 days | |
| PeptiraUS | $149$1.86/mg · 80mg | COA with shipment | 3 days | Out of stock |
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Week 1–2
Per protocol.
Initiation
Week 3–4
Per protocol.
Signal emerges
Week 5–8
Per protocol.
Hold
Week 9–12
Cycle review
Assess
Draw 3 units.
1 mg = 0.03 mL at 40.00 mg/mL. 80.0 doses per vial.
niche · III · Ameano Peptides
KLOW Blend · 80mg